Actively Recruiting

Phase 4
Age: 18Years - 65Years
All Genders
NCT06215976

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Led by Cairo University · Updated on 2024-08-20

78

Participants Needed

1

Research Sites

82 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to evaluate the protective effect of metformin on nephrotoxicity of cisplatin in patients with bladder cancer. The main questions it aims to answer are: * To determine protective effect of metformin on structural and functional kidney injury caused by cisplatin in patients with bladder cancer. * To evaluate the safety of combining cisplatin and metformin on patients with bladder cancer

CONDITIONS

Official Title

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 65 years
  • Non-diabetic patients diagnosed with bladder cancer who have not had chemotherapy before
  • Patients with stable kidney function, defined as an estimated glomerular filtration rate (eGFR) above 60 ml/min/1.73 m2
Not Eligible

You will not qualify if you...

  • History of lactic acidosis
  • Use of nephrotoxic medications other than cisplatin (such as frusemide, NSAIDs, aminoglycosides, or vancomycin)
  • Unstable kidney function with sudden serum creatinine increase of 0.3 mg/dL or more within 48 hours
  • Heart failure, acute myocardial infarction, or cardiogenic shock
  • Severe infections or sepsis requiring hospitalization or intensive support such as oxygen, intubation, vasopressors, or fluids
  • Alcohol intake
  • Respiratory failure
  • Severe liver impairment classified as Child-Pugh class C
  • Presence of cancer metastasis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

faculty of pharmacy Cairo university

Cairo, Egypt

Actively Recruiting

Loading map...

Research Team

S

Samah Essam Saber Mahran

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here